Labiana Health S.A. (LAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Labiana Health S.A. (LAB) has a cash flow conversion efficiency ratio of 0.604x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.68 Million ≈ $5.47 Million USD) by net assets (€7.74 Million ≈ $9.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Labiana Health S.A. (LAB) balance sheet quality index to measure how much of total assets are equity-financed.
Labiana Health S.A. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Labiana Health S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LAB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Labiana Health S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Labiana Health S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
JHM Consolidation Bhd
KLSE:0127
|
-0.009x |
|
Bafna Pharmaceuticals Limited
NSE:BAFNAPH
|
0.093x |
|
Savezone I C
KO:067830
|
-0.003x |
|
JLS Co.Ltd
KQ:040420
|
0.043x |
|
Annovis Bio Inc
NYSE:ANVS
|
-0.530x |
|
OT Logistics S.A
WAR:OTS
|
0.101x |
|
Dish TV India Limited
NSE:DISHTV
|
-0.029x |
|
Birla Cable Limited
NSE:BIRLACABLE
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Labiana Health S.A. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Labiana Health S.A. from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Labiana Health S.A..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €2.57 Million ≈ $3.00 Million |
€7.19 Million ≈ $8.41 Million |
2.801x | +622.10% |
| 2023-12-31 | €3.40 Million ≈ $3.98 Million |
€-1.83 Million ≈ $-2.13 Million |
-0.536x | -188.78% |
| 2022-12-31 | €7.74 Million ≈ $9.05 Million |
€4.68 Million ≈ $5.47 Million |
0.604x | +78.22% |
| 2021-12-31 | €11.52 Million ≈ $13.47 Million |
€3.91 Million ≈ $4.57 Million |
0.339x | -- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more